Berman Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1K | Buy |
22
+14
| +175% | +$636 | ﹤0.01% | 1902 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1978 |
|
|
2021
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1845 |
|
|
2020
Q2 | – | Sell |
-32
| Closed | -$1K | – | 1736 |
|
|
2020
Q1 | $1K | Sell |
32
-50
| -61% | -$1.56K | ﹤0.01% | 1323 |
|
|
2019
Q4 | $5K | Hold |
82
| – | – | ﹤0.01% | 978 |
|
|
2019
Q3 | $5K | Buy |
82
+52
| +173% | +$3.17K | ﹤0.01% | 945 |
|
|
2019
Q2 | $2K | Sell |
30
-5
| -14% | -$333 | ﹤0.01% | 1206 |
|
|
2019
Q1 | $2K | Buy |
35
+25
| +250% | +$1.43K | ﹤0.01% | 1104 |
|
|
2018
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1203 |
|